Content section
Regulatory Pulse
Regulatory Pulse checks CQC, ASA, GPhC, DHSC, Scottish legislation and MHRA activity every week. Each edition records material changes, confirms quiet sources and connects developments to CheckMyClinic's existing analysis.
-
Botulism symptoms can take four weeks
MHRA repeats botulinum toxin safety warnings, including a four-week symptom window, as our weekly scan finds no other target-sector regulatory change.
-
Scotland exposes aesthetic data gap
Scotland cannot produce consistent national data on aesthetic complications. Our weekly scan tracks what changed across six UK regulatory sources this week.
-
Private scripts surged 134% — CQC report
Weekly regulatory scan: CQC reports a 134% rise in private CBPM prescribing and records what changed across six UK regulatory sources.